Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912163197> ?p ?o ?g. }
- W2912163197 endingPage "e181" @default.
- W2912163197 startingPage "e173" @default.
- W2912163197 abstract "Background The risk of venous thrombotic events is elevated in people with HIV, but overall risk estimates and estimates specific to immune status and antiretroviral medication remain i mprecise. In this study, we aimed to estimate these parameters in a large cohort of people with HIV in the Netherlands. Methods In this retrospective cohort study, we used the Dutch ATHENA cohort to estimate crude, age and sex standardised, and risk period-specific incidences of a first venous thrombotic event in people with HIV aged 18 years or older attending 12 HIV treatment centres in the Netherlands. Crude and standardised incidences were compared with European population-level studies of venous thrombotic events. We used time-updated Cox regression to estimate the risk of a first venous thrombotic event in association with HIV-specific factors (CD4 cell count, viral load, recent opportunistic infections, antiretroviral medication use) adjusted for traditional risk factors for venous thrombotic events. Findings With data collected from Jan 1, 2003, to April 1, 2015, our study cohort included 14 389 people with HIV and 99 762 person-years of follow-up, with a median follow-up of 7·2 years (IQR 3·3–11·1). During this period, 232 first venous thrombotic events occurred, yielding a crude incidence of 2·33 events per 1000 person-years (95% CI 2·04–2·64) and an incidence standardised for age and sex of 2·50 events per 1000 (2·18–2·82). CD4 counts less than 200 cells per μL were independently associated with higher risk of a venous thrombotic event: adjusted hazard ratio (aHR) 3·40 (95% CI 2·28–5·08) relative to counts of 500 cells per μL. A high viral load (aHR 3·15, 95% CI 2·00–5·02; >100 000 copies per mL vs <50 copies per mL) and current or recent opportunistic adverse events (2·80, 1·77–4·44) were also independently associated with higher risk of a venous thrombotic event. There were no associations between any specific antiretroviral drugs and risk of a venous thrombotic event. Rates associated with pregnancy (9·4, 95% CI 4·6–17·3), malignancy (16·7, 10·6–25·1), and hospitalisation (24·4, 19·1–30·6) were lower than primary thromboprophylaxis thresholds suggested by the respective guidelines. Interpretation Our findings support neither prescribing primary outpatient thromboprophylaxis nor avoiding any type of antiretroviral medication in people with HIV at high risk of a venous thrombotic event. Funding Dutch Ministry of Health, Welfare and Sport." @default.
- W2912163197 created "2019-02-21" @default.
- W2912163197 creator A5001375239 @default.
- W2912163197 creator A5013392551 @default.
- W2912163197 creator A5025109424 @default.
- W2912163197 creator A5031923033 @default.
- W2912163197 creator A5035631448 @default.
- W2912163197 creator A5037944984 @default.
- W2912163197 creator A5038007995 @default.
- W2912163197 creator A5041859079 @default.
- W2912163197 creator A5042865598 @default.
- W2912163197 creator A5044888668 @default.
- W2912163197 creator A5045157191 @default.
- W2912163197 creator A5047855521 @default.
- W2912163197 creator A5056575262 @default.
- W2912163197 creator A5059433450 @default.
- W2912163197 creator A5064822409 @default.
- W2912163197 creator A5066119745 @default.
- W2912163197 creator A5067277048 @default.
- W2912163197 creator A5069096181 @default.
- W2912163197 creator A5071790578 @default.
- W2912163197 creator A5075640648 @default.
- W2912163197 creator A5078149559 @default.
- W2912163197 creator A5082840819 @default.
- W2912163197 creator A5091291619 @default.
- W2912163197 date "2019-03-01" @default.
- W2912163197 modified "2023-10-17" @default.
- W2912163197 title "Incidence of a first venous thrombotic event in people with HIV in the Netherlands: a retrospective cohort study" @default.
- W2912163197 cites W1488316909 @default.
- W2912163197 cites W1533954772 @default.
- W2912163197 cites W1835708151 @default.
- W2912163197 cites W1989576769 @default.
- W2912163197 cites W1993297869 @default.
- W2912163197 cites W2036441262 @default.
- W2912163197 cites W2039816125 @default.
- W2912163197 cites W2075409030 @default.
- W2912163197 cites W2093389482 @default.
- W2912163197 cites W2093931830 @default.
- W2912163197 cites W2106296789 @default.
- W2912163197 cites W2110992040 @default.
- W2912163197 cites W2118247493 @default.
- W2912163197 cites W2129338539 @default.
- W2912163197 cites W2137860092 @default.
- W2912163197 cites W2142237458 @default.
- W2912163197 cites W2155593081 @default.
- W2912163197 cites W2238552371 @default.
- W2912163197 cites W2323452366 @default.
- W2912163197 cites W2407139997 @default.
- W2912163197 cites W2477143702 @default.
- W2912163197 cites W2560019320 @default.
- W2912163197 cites W2563615594 @default.
- W2912163197 cites W2591786778 @default.
- W2912163197 cites W2595034493 @default.
- W2912163197 cites W2891129221 @default.
- W2912163197 doi "https://doi.org/10.1016/s2352-3018(18)30333-3" @default.
- W2912163197 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30777727" @default.
- W2912163197 hasPublicationYear "2019" @default.
- W2912163197 type Work @default.
- W2912163197 sameAs 2912163197 @default.
- W2912163197 citedByCount "17" @default.
- W2912163197 countsByYear W29121631972019 @default.
- W2912163197 countsByYear W29121631972020 @default.
- W2912163197 countsByYear W29121631972021 @default.
- W2912163197 countsByYear W29121631972022 @default.
- W2912163197 countsByYear W29121631972023 @default.
- W2912163197 crossrefType "journal-article" @default.
- W2912163197 hasAuthorship W2912163197A5001375239 @default.
- W2912163197 hasAuthorship W2912163197A5013392551 @default.
- W2912163197 hasAuthorship W2912163197A5025109424 @default.
- W2912163197 hasAuthorship W2912163197A5031923033 @default.
- W2912163197 hasAuthorship W2912163197A5035631448 @default.
- W2912163197 hasAuthorship W2912163197A5037944984 @default.
- W2912163197 hasAuthorship W2912163197A5038007995 @default.
- W2912163197 hasAuthorship W2912163197A5041859079 @default.
- W2912163197 hasAuthorship W2912163197A5042865598 @default.
- W2912163197 hasAuthorship W2912163197A5044888668 @default.
- W2912163197 hasAuthorship W2912163197A5045157191 @default.
- W2912163197 hasAuthorship W2912163197A5047855521 @default.
- W2912163197 hasAuthorship W2912163197A5056575262 @default.
- W2912163197 hasAuthorship W2912163197A5059433450 @default.
- W2912163197 hasAuthorship W2912163197A5064822409 @default.
- W2912163197 hasAuthorship W2912163197A5066119745 @default.
- W2912163197 hasAuthorship W2912163197A5067277048 @default.
- W2912163197 hasAuthorship W2912163197A5069096181 @default.
- W2912163197 hasAuthorship W2912163197A5071790578 @default.
- W2912163197 hasAuthorship W2912163197A5075640648 @default.
- W2912163197 hasAuthorship W2912163197A5078149559 @default.
- W2912163197 hasAuthorship W2912163197A5082840819 @default.
- W2912163197 hasAuthorship W2912163197A5091291619 @default.
- W2912163197 hasBestOaLocation W29121631972 @default.
- W2912163197 hasConcept C120665830 @default.
- W2912163197 hasConcept C121332964 @default.
- W2912163197 hasConcept C126322002 @default.
- W2912163197 hasConcept C167135981 @default.
- W2912163197 hasConcept C187212893 @default.
- W2912163197 hasConcept C201903717 @default.
- W2912163197 hasConcept C2908647359 @default.
- W2912163197 hasConcept C50382708 @default.